Publications – LDS – Lyotropic Delivery System

News

Showcasing Advanced Technology: Ocuvia™ LDS-Based Ophthalmic Drug Delivery, Presented at the 43rd Annual J.P. Morgan Healthcare Conference

January 13, 2025

Biolight Presents LDS’ Novel Ophthalmic Technology at the 43rd J.P. Morgan Conference

UCLA David Geffen School of Medicine and Ananda Scientific Announce: Commencement of a Clinical Trial Evaluating Nantheia™ ATL5 for Smoking Cessation

October 22, 2024

ANANDA Scientific Press Release: Advancing Smoking Cessation Treatments with LDS Liquid Structure™ Delivery Technology

Yale School of Medicine and Ananda Scientific Announce FDA-Approved Clinical Trial for Nantheia™ ATL5: A Breakthrough Treatment for Opioid Use Disorder and Chronic Pain

October 15, 2024

ANANDA Scientific Press Release: Advancing Opioid Use Disorder (OUD) and Chronic Pain Treatments with LDS Liquid Structure™ Delivery Technology

LDS Technology Presented at the Adult Poly-Body Disease (APBD) Conference: Driving Solutions for Orphan Indication Treatment

September 19, 2024

Golden Heart Flower (GHF) Showcases LDS’ Novel Delivery Technology at the APBD Scientific & Community Conference

LDS Scientific Paper Publication: Revolutionizing Astaxanthin Delivery with Enhanced Bioavailability and Improved Efficacy Using LDS’ Novel Delivery System

July 18, 2024

LDS’s Breakthroughs Published in the International Journal of Molecular Sciences (Int. Mol. Sci. 2024, 25, Pages 2-18)

LDS Presents at the 2024 MIXiii Health-Tech Conference: The Future of Innovation in Drug Delivery Solutions

March 5, 2024

LDS Poster and Presentation at the 2024 MIXiii Health-Tech Conference

Global Breakthrough: An Exclusive Licensing Option Agreement Signed with a Leading Pharmaceutical Company for Its Novel LDS-Based Ophthalmic Product

February 29, 2024

BioLight Life Sciences Press Announcement

חברת אופרקס מודיעה על קבלת תוצאות חיוביות בניסוי קליני של ציקלוספורין במתן אופטלמי בטכנולוגיה הייחודית של החברה

August 16, 2023

חברת ביולייט מדעי החיים וחברת אופרקס (חברת הבת) מודיעה לעיתונות על קבלת תוצאות חיוביות בסיום ניסוי הקליני המבוסס על טכנולוגיה

NYU Grossman School of Medicine and Ananda Scientific Announce: First Patient Enrolled in FDA-Approved Clinical Trial for a Potential New Treatment for Social Anxiety Disorder (SAD)

March 28, 2023

ANANDA Scientific Press Release: Advancing Social Anxiety Disorder (SAD) Treatments with LDS Liquid Structure™ Delivery Technology